Increased risk of colorectal neoplasia in adult patients with cystic fibrosis: A matched case-control study

Scandinavian Journal of Gastroenterology

Volumn 49, Issue 10, 2014, Pages 1230-1236

  Gory, Ilana ^a   Brown, Gregor ^a   Wilson, John ^a   Kemp, William ^a   Paul, Eldho ^b   Roberts, Stuart K ^a  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Adenomas; Case control; Colorectal cancer; Cystic fibrosis

Indexed keywords

ADULT; ADVANCED ADENOMA; ADVANCED CANCER; ARTICLE; CANCER GROWTH; CANCER RISK; CASE CONTROL STUDY; CLINICAL ARTICLE; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; COLORECTAL POLYP; COLORECTAL TUMOR; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE ASSOCIATION; EXPLORATORY RESEARCH; FEMALE; HUMAN; INTESTINE PREPARATION; MALE; RECTUM HEMORRHAGE; RETROSPECTIVE STUDY; ADENOCARCINOMA; ADENOMA; COLORECTAL NEOPLASMS; COMPLICATION; ILEAL NEOPLASMS; MIDDLE AGED; RISK ASSESSMENT; STANDARDS;

ADENOCARCINOMA; ADENOMA; ADULT; CASE-CONTROL STUDIES; COLONOSCOPY; COLORECTAL NEOPLASMS; CYSTIC FIBROSIS; FEMALE; HUMANS; ILEAL NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84907257157     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2014.936035     Document Type: Article

References (38)

1. Cystic Fibrosis Australia,Inc. [online]. 2012. Available from http:www.cysticfibrosisaustralia.org.au. Accessed October 2012.
2. Cohn JA, Strong TV, Picciotto MR, Nairn AC, Collins FS, Fitz JG. Localization of the cystic fibrosis transmembrane conductance regulator in human bile dict epithelial cells. Gastroenterology 1993;105:1857-64.
3. FitzSimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr 1993;122:1-9.
4. Reid DW, Blizzard CL, Shugg DM, Flowers C, Cash C, Greville HM. Changes in cystic fibrosis mortality in Australia, 1979-2005. Med J Aust 2011;195:392-5.
5. Dodge JA, Lewis PA, Stanton M, Wilsher J. Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur Respir J 2007;29:522-6.
6. Bellis G, Cazes MH, Parant A, Gaimard M, Travers C, Le Roux E, et al. Cystic fibrosis mortality trends in France. J Cyst Fibros 2007;6:179-86.
7. Ramalle-Gomara E, Perucha M, González MA, Quiñones C, Andrés J, Posada M. Cystic fibrosis mortality trends in Spain among infants and young children: 1981-2004. Eur J Epidemiol 2008;23:523-9.
8. Hernandez-Jimenez I, Fischman D, Cheriyath P. Colon cancer in cystic fibrosis patients: Is this a growing problem? J Cyst Fibros 2008;7:343-6.
9. Meyer KC, Francois ML, Radford KL, Hawes DS, Mack TL, Cornwell RD. Colon cancer in lung transplant recipients with CF: Increased risk and results of screening. J Cyst Fibros 2011;10:366-9.
10. Neglia JP, Fitzsimons SC, Maisonneuve P, Schöni MH, Schöni-Affolter F, Corey M, et al. The Cystic Fibrosis and Cancer Study Group. The risk of cancer among patients with cystic fibrosis. N Engl J Med 1995;332:494-9.
11. Maisonneve P, Marshall BC, Knapp EA, Lowenfels AB. Cancer risk in cystic fibrosis patients: A 20-year nationwide study. J Natl Cancer Inst 2013;105:122-9.
12. Abdul-Karim FW, King TA, Dahms BB, Gauderer MW, Boat TF. Carcinoma of extrahepatic biliary system in a patient with cystic fibrosis. Gastroenterology 1982;82:758-62.
13. Naderi AS, Farsian FN, Lee WM. Cholangiocarcinoma after lung transplantation in a patient with cystic fibrosis. Eur J Gastroenterol Hepatol 2008;20:1115-17.
14. Prost DJ, Hubert D, Gaudric M, Scatton O, Soubrane O. Pancreatic mucinous cystadenoma in an adult with cystic fibrosis. Clin Res Hepatol Gastroenterol 2011;35:759-61.
15. Roberts JA, Tullett WM, Thomas JS, Galloway D, Stack BH. Bowel adenocarcinoma in a patient with cystic fibrosis. Scott Med J 1986;31:109.
16. McKenna PB, Mulcahy E, Waldron D. Early onset of colonic adenocarcinoma associated with cystic fibrosis-A case report. Ir Med J 2006;99:310-11.
17. Alexander CL, Urbanski SJ, Hilsden R, Rabin H, MacNaughton WK, Beck PL. The risk of gastrointestinal malignancies in cystic fibrosis: Case report of a patient with a near obstructing villous adenoma found on colon cancer screening and Barrett's esophagus. J Cyst Fibros 2008;7:1-6.
18. Ibele AR, Koplin SA, Slaughenhoupt BL, Kryger JV, Friedl A, Lund DP. Colonic adenocarcinoma in a 13 year old with cystic fibrosis. J Pediatr Surg 2007;42:E1-3.
19. Chaun H, Paty B, Nakielna EM, Schmidt N, Holden JK, Melosky B. Colonic Cancer in two adult CF patients. Can J Gastroenterol 1996;10:440-2.
20. Sheldon CD, Hodson ME, Carpenter LM, Swerdlow AJ. A cohort study of cystic fibrosis and malignancy. Br J Cancer 1993;68:1025-8.
21. SchoniMH,Maisonneuve P,Schoni-AffolterF,LowenfelsAB. Cancer risk in patients with cystic fibrosis: The European Data. J R Soc Med 1996;89:38-43.
22. Johannesson M, Askling J, Montgomery SM, Ekbom A, Bahmanyar S. Cancer risk among patients with cystic fibrosis and their first degree relatives. Int J Cancer 2009;125: 2953-6.
23. Neglia JP, Wielinski CL, Warwick WJ. Cancer risk among patients with cystic fibrosis. J Pediatr 1991;119:764-6.
24. Australian Institute of Health and Welfare. Cancer in Australia 2010: An overview. Cancer series no. 60. Cat no. CAN 56 Canberra: AIHW; 2010.
25. Stryker SJ, Wolff BG, Culp CE, et al. Natural history of untreated colonic polyps. Gastroenterology 1987;93: 1009-13.
26. Otchy DP, Ransonhoff DF, Wolff BG, Weaver A, Ilstrup D, Carlson H, et al. Metachronous colon cancer in persons who have a large adenomatous polyp. Am J Gastroenterol 1996; 91:448-54.
27. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008;134:1570-95.
28. Modolell I, Guarner L, Malagelada JR. Digestive system involvement in cystic fibrosis. Pancreatology 2002;2:12-16.
29. Bali A, Stableforth DE, Asquith P. Prolonged small-intestinal transit time in cystic fibrosis. Br Med J (Clin Res Ed) 1983; 287:1011-13.
30. Fridge JL, Conrad C, Gerson L, Castillo RO, Cox K. Risk factors for small bowel bacterial overgrowth in cystic fibrosis. J Pediatr Gastroenterol Nutr 2007;44:212-18.
31. Werlin SL, Benuri-Silbiger I, Kerem E, Adler SN, Goldin E, Zimmerman J, et al. Evidence of intestinal inflammation in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2010;51:304-8.
32. Stead RJ, Redington AN, Hinks IJ, Clayton BE, Hodson ME, Batten JC. Selenium deficiency and possible increased risk of carcinoma in adults with cystic fibrosis. Lancet 1985;2:862-3.
33. Kune G, Watson L. Colorectal cancer protective effects and the dietary micronutrients folate, methionine, vitamins B6, B12, C, E, selenium, and lycopene. Nutr Cancer 2006;56: 11-21.
34. Rose DP, Connolly JM. Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol Ther 1999;83:217-44.
35. Strandvik B, Gronowitz E, Enlund F, Martinsson T, Wahlström J. Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis. J Pediatr 2001;139: 650-5.
36. Button BM, Roberts S, Kotsimbos TC, Levvey BJ, Williams TJ, Bailey M, et al. Gastroesophageal reflux (symptomatic and silent): A potentially significant problem in patients with cystic fibrosis before and after lung transplantation. J Heart Lung Transplant 2005;24:1522-9.
37. The Transplantation Society of Australia and New Zealand [online]. 2012. Available from www.tsanz.com.au/organallocationprotocols/ lungprotocol.asp. Accessed November 2012.
38. Gordon CM, Anderson EJ, Herlyn K, Hubbard JL, Pizzo A, Gelbard R, et al. Nutrient status of adults with cystic fibrosis. J Am Diet Assoc 2007;107:2114-19.